Skip to Main Content

Editors Choice

1 Results

Original Article Mesothelioma
Open Archive
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma
Journal of Thoracic Oncology
Vol. 11Issue 6p900–909Published online: February 20, 2016
- Harvey I. Pass
- Chandra Goparaju
- Osvaldo Espin-Garcia
- Jessica Donington
- Michele Carbone
- Devalben Patel
- and others
Cited in Scopus: 20
Prognostic models for malignant pleural mesothelioma (MPM) are needed to prevent potentially futile outcomes. We combined MPM plasma biomarkers with validated clinical prognostic indices to determine whether stratification of risk for death in 194 patients with MPM improved.